Results 261 to 270 of about 1,090,016 (327)
Some of the next articles are maybe not open access.

Precision Medicine in Biliary Tract Cancer.

Journal of Clinical Oncology, 2022
Precision medicine has become a dominant theme in the treatment of biliary tract cancers (BTCs). Although prognosis remains poor, technologies for improved molecular characterization along with the US Food and Drug Administration approval of several ...
A. Scott, R. Sharman, R. Shroff
semanticscholar   +1 more source

Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer

Expert Review of Gastroenterology & Hepatology, 2021
Introduction: Unfortunately, potentially curative surgical resection is possible in approximately the 25% of biliary tract cancer (BTC) patients at diagnosis, and even following radical surgery, relapse rates remain high.
A. Rizzo, G. Brandi
semanticscholar   +1 more source

Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death‐Ligand 1 Blockade Responses

Hepatology, 2021
Biliary tract cancer (BTC) exhibits diverse molecular characteristics. However, reliable biomarkers that predict therapeutic responses are yet to be discovered.
Jihoon G. Yoon   +12 more
semanticscholar   +1 more source

Imaging of the biliary tract

Current Opinion in Gastroenterology, 2023
Purpose of review Magnetic resonance cholangiopancreatography (MRCP) has become the reference examination for the exploration of the biliary tract and has replaced endoscopic cholangiography for the analysis of the biliary tract because of its equivalent performance and its noninvasive character.
Pauline, Iorio   +3 more
openaire   +2 more sources

Biliary tract dysmotility

Current Treatment Options in Gastroenterology, 1998
Biliary pain resulting from motility disorders is common and may be overlooked due to the difficulty of diagnosing the presence of these disorders. A sound, logical approach to the evaluation and treatment of these specific groups of disorders is essential.
, Lichtenstein, , Dabezies
openaire   +2 more sources

Carcinoid of the Biliary Tract

Archives of Surgery, 1964
Carcinoid tumors are derived from Kultschitsky cells or their precursors and have the potential to produce serotonin 5-hydroxytryptamine or 5-hydroxytryptophan. The predominance of carcinoids in the intestinal tract is well known, especially in the region of the ileocecal valve where Kultschitsky cells are numerous.
M, SHIFFMAN, G, JULER
openaire   +2 more sources

Infections of the Biliary Tract

Gastrointestinal Endoscopy Clinics of North America, 2013
Infection of the biliary tract, or cholangitis, is a potentially life-threatening condition. Bile duct stones are the most common cause of biliary obstruction predisposing to cholangitis. The key components in the pathogenesis of cholangitis are biliary obstruction and biliary infection.
Rajan, Kochar, Subhas, Banerjee
openaire   +2 more sources

Surgery of the Biliary Tract

New England Journal of Medicine, 1956
Stenosis of the Sphincter of Oddi The validity of the concept that stenosis of the sphincter of Oddi contributes to biliary-tract symptoms is gradually gaining support. It is being recognized with increasing frequency as a pathologic fact both at the time of initial cholecystectomy and as a cause of continued or recurrent symptoms in some patients ...
R B, CATTELL, K W, WARREN
openaire   +3 more sources

Recent advances of immunotherapy for biliary tract cancer

Expert Review of Gastroenterology & Hepatology, 2020
Introduction: Biliary tract cancer (BTC) is a heterogeneous group of aggressive malignancies comprising intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, gallbladder cancer, and ampulla of Vater cancer.
A. Rizzo, A. Ricci, G. Brandi
semanticscholar   +1 more source

Biliary tract cancer

Current Opinion in Gastroenterology, 1999
Recent advances in the molecular and cellular biology, diagnosis, and treatment of biliary tract cancer are reviewed. Several studies have delineated the molecular and cellular biology of cholangiocarcinoma and gallbladder carcinoma. Hepatocyte growth factor seems to be mitogenic to gallbladder carcinoma, and its inhibition may have a therapeutic role ...
J A, Ehrenfried, J N, Vauthey
openaire   +2 more sources

Home - About - Disclaimer - Privacy